KELLY CZARNECKI: Open Payments
NPI 1043234610 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 6 companies in 2025. Trend: 2023 $370 · 2024 $339 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| ABBVIE INC. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Genentech USA, Inc. | 1 | $23 |
| UCB, Inc. | 1 | $17 |
| Organon LLC | 1 | $16 |
Products named: DUPIXENT, COSENTYX, Xolair, SKYRIZI, Bimzelx, VTAMA, BOTOX.
Industry payments across AZ — which companies pay providers there.
